<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://arg.alphagenics.co/blog/arg-anmat-bioequivalencia-disposicion-7204-2026-genericos/</loc><news:news><news:publication><news:name>Alphagenics Argentina</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>ANMAT y bioequivalencia: Disposición 7204/2026, qué cambia</news:title></news:news></url><url><loc>https://arg.alphagenics.co/blog/arg-anmat-endoprotesis-robadas-gore-viabahn-vbx-disposicion-7199-2026/</loc><news:news><news:publication><news:name>Alphagenics Argentina</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>ANMAT prohíbe 3 endoprótesis Gore Viabahn VBX robadas</news:title></news:news></url><url><loc>https://arg.alphagenics.co/blog/arg-nmn-nad-suplementos-antiedad-anmat-ensayos-humanos/</loc><news:news><news:publication><news:name>Alphagenics Argentina</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>NMN y NAD+ en Argentina: ensayos y qué exige la ANMAT</news:title></news:news></url></urlset>
